GlassScriptPhysician profile
Steven Warren Graeca
NPI 1295765030
$5,185.46
in general payments reported to CMS, 2019-2025
44 companies · $963 in 2025
The $963 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $170 · 2021: $486 · 2022: $782 · 2023: $728 · 2024: $1,144 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,426 · Education: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,425.79 |
| Education | $409.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $917.54 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $594.25 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $464.47 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $388.82 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $335.04 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $267.53 | 2023-2025 | Farxiga, Airsupra, Breztri |
| E.R. Squibb & Sons, L.L.C. | $251.32 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $185.60 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $178.01 | 2019-2025 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $172.88 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $156.33 | 2022-2023 | Arexvy, Shingrix, Benlysta |
| Novartis Pharmaceuticals Corporation | $107.55 | 2019-2024 | |
| Pfizer INC. | $90.82 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $81.78 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Dexcom, INC. | $79.74 | 2021-2025 | Dexcom G6 Transmitter |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Graeca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.